Caxton Corp as of March 31, 2018
Portfolio Holdings for Caxton Corp
Caxton Corp holds 23 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Strongbridge Bioph shs usd | 55.1 | $47M | 5.4M | 8.80 | |
| Garrison Capital | 10.5 | $9.1M | 1.1M | 8.12 | |
| Molecular Templates | 9.7 | $8.3M | 1.0M | 8.00 | |
| Cm Fin | 7.7 | $6.6M | 810k | 8.20 | |
| Agile Therapeutics | 5.4 | $4.7M | 1.8M | 2.57 | |
| Berkshire Hathaway (BRK.B) | 2.2 | $1.9M | 9.3k | 199.53 | |
| Jbg Smith Properties (JBGS) | 1.6 | $1.4M | 41k | 33.71 | |
| PG&E Corporation (PCG) | 1.1 | $988k | 23k | 43.91 | |
| Amer (UHAL) | 1.1 | $932k | 2.7k | 345.19 | |
| Gtx Inc Del | 1.0 | $877k | 49k | 17.76 | |
| Triangle Capital Corporation | 0.6 | $543k | 49k | 11.12 | |
| Fs Investment Corporation | 0.6 | $508k | 70k | 7.25 | |
| Anheuser-Busch InBev NV (BUD) | 0.6 | $486k | 4.4k | 109.83 | |
| Alcentra Cap | 0.5 | $446k | 64k | 6.95 | |
| Intec Pharma | 0.5 | $395k | 64k | 6.14 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $370k | 21k | 17.50 | |
| Scynexis | 0.3 | $259k | 193k | 1.34 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $233k | 2.0k | 116.56 | |
| Adient (ADNT) | 0.3 | $229k | 3.8k | 59.67 | |
| Dicerna Pharmaceuticals | 0.1 | $125k | 13k | 9.56 | |
| Marinus Pharmaceuticals | 0.1 | $102k | 27k | 3.80 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $86k | 36k | 2.38 | |
| Sierra Oncology | 0.1 | $78k | 38k | 2.08 |
